MARKET

BJDX

BJDX

Bluejay Diagnostics Inc
NASDAQ
0.4027
-0.0080
-1.95%
Opening 09:30 01/30 EST
OPEN
0.4057
PREV CLOSE
0.4107
HIGH
0.4057
LOW
0.4027
VOLUME
4.25K
TURNOVER
1.75K
52 WEEK HIGH
1.830
52 WEEK LOW
0.2779
MARKET CAP
8.12M
P/E (TTM)
-0.9690
1D
5D
1M
3M
1Y
5Y
BRIEF-Bluejay Diagnostics Inc Entered Into An Amendment To Company's Employment Agreement With CEO Neil Dey
Reuters · 2d ago
12 Health Care Stocks Moving In Monday's Pre-Market Session
Benzinga · 01/02 13:05
Why Ambrx Biopharma Shares Are Trading Higher By Over 550%? Here Are 52 Stocks Moving In Friday's Mid-Day Session
Benzinga · 12/09/2022 18:48
12 Health Care Stocks Moving In Friday's Intraday Session
Benzinga · 12/09/2022 17:32
12 Health Care Stocks Moving In Tuesday's After-Market Session
Benzinga · 11/15/2022 21:32
Bluejay Diagnostics, Inc. (NASDAQ:BJDX) drops to US$14m and insiders who purchased earlier this year lose another US$65k
Insiders who acquired US$183k worth of Bluejay Diagnostics, Inc.'s ( NASDAQ:BJDX ) stock at an average price of US$1.09...
Simply Wall St. · 11/13/2022 13:01
BRIEF-Bluejay Diagnostics Reports Third Quarter Results
Reuters · 11/09/2022 14:39
Bluejay Diagnostics GAAP EPS of -$0.15
Seekingalpha · 11/09/2022 13:53
More
About BJDX
Bluejay Diagnostics, Inc. is engaged in the developing medical diagnostics tests devices. The Company offers diagnostic testing in infectious, inflammatory and metabolic diseases by using its Symphony platform. Symphony platform is an automated diagnostic system, consisting of a fluorescence immuno-analyzer which uses a single-use diagnostic test cartridge with reagents integrated in the cartridge. The Company is developing a pipeline of diagnostic tests for Symphony, including triage of myocardial infarction (MI), congestive heart failure (CHF), neutropenic sepsis in cancer, and other disease diagnostic indications using the same Symphony platform. The Company's Symphony IL-6 product candidate is for early and rapid identification of sepsis during Emergency Department (ED), critical care triage, and neutropenic sepsis in oncology patients. Symphony IL-6 product candidate is also for monitoring disease progression during such treatment regimen.

Webull offers kinds of Bluejay Diagnostics Inc stock information, including NASDAQ:BJDX real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, BJDX stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading BJDX stock methods without spending real money on the virtual paper trading platform.